Sort
48,018 grants matching “immunotherapy”
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$430,292Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
$430,262Raymond J Budde · Houston Pharmaceuticals, Inc. · R44 · FY2010 · AI
The integrated stress response and the microenvironment in melanoma progression
$430,251Constantinos Koumenis · University Of Pennsylvania · R01 · FY2022 · CA
Brain Tumor Immunotherapy
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Rare Central Nervous System Cancers Initiative
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$430,212Edgar G. Engleman · Stanford University · P01 · FY2025 · CA
TNF Mediated Immune Defense Against Listeria Infection
$430,201Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2008 · AI
Project 2
$430,137Rory Smoot · Mayo Clinic Rochester · P50 · FY2024 · CA
Neuroprotective B Cell Immunotherapy for Contusion Traumatic Brain Injury
$430,073Ruxandra F Sirbulescu · Massachusetts General Hospital · R01 · FY2021 · NS
Project 1: Glutaminolytic GDH1 activation-dependent immunotherapy resistance in LKB1-mutant lung adenocarcinoma
$430,062Sumin Kang · Emory University · P01 · FY2022 · CA
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
$430,054Victor H. Engelhard · University Of Virginia · R01 · FY2014 · CA
Chemotherapy plus vaccine for metastatic breast cancer
$429,983Johns Hopkins University · R01 · FY2004 · CA
Regulation of CD8+T cells by Zbtb42
$429,966Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · CA
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$429,953Eric T. Kool · Stanford University · R01 · FY2017 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$429,943Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy
$429,937Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
$429,934Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2010 · CA
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptides
$429,912Edward A Botchwey · Georgia Institute Of Technology · R56 · FY2020 · DE
Project 1
$429,899Mark A Atkinson · University Of Florida · P01 · FY2024 · AI
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$429,847Anna Pomes · Indoor Biotechnologies · R01 · FY2012 · AI
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$429,841Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
An integrative structural biology approach to the study of T cell signaling
$429,833Nikolaos Sgourakis · Children'S Hosp Of Philadelphia · R35 · FY2020 · GM
An integrative structural biology approach to the study of T cell signaling
$429,833Nikolaos Sgourakis · Children'S Hosp Of Philadelphia · R35 · FY2021 · GM
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$429,815Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
ApoVax104-TB as a Novel Vaccine for Tuberculosis
$429,811Kathryn J. Macleod · Apovax, Inc. · R43 · FY2009 · AI